Plus   Neg

Vanda Pharmaceuticals Inc. (VNDA) Is Rising After S&P Index Change

It was announced after the bell Tuesday that Vanda Pharmaceuticals Inc. (VNDA) will replace Inogen (INGN) in the S&P SmallCap 600 prior to the open on Monday, October 1.

Vanda Pharmaceuticals gapped open sharply higher Wednesday morning and is now up 2.20 at $22.85. The stock has risen to over a month and a half high.

For comments and feedback contact: editorial@rttnews.com

Business News


0 Articles
Follow RTT